Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A LINDEMANN

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
FEBS Letters|September 17, 1990
Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxinL Mantovani, R Henschler, M A Brach, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 24, 2001
Trimethylsilyl- and trimethylstannyldimethylphosphane--convenient and versatile reagents for the synthesis of polyfluoroaryldimethylphosphanesL I Goryunov, J Grobe, V D Shteingarts, et al.
Blut|February 1, 1990
Erythropoietin prevents chemotherapy-induced anemia: case reportW Oster, F Herrmann, A Cicco, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2A Lindemann, P Brossart, K Höffken, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 1994
[Radiologic differential diagnosis of inflammatory round pulmonary infiltrates in immunocompromised patients. A prospective study using CT and MRT]U Blum, M Windfuhr, C Buitrago-Tellez, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB studyA Lindemann, P Brossart, K Höffken, et al.
Biotechnology Therapeutics|January 1, 1992
Combination of interleukin-2 and interferon-alpha in renal cell carcinoma and malignant melanoma: a phase II clinical trialH Veelken, F M Rosenthal, F Schneller, et al.
British Journal of Cancer|June 1, 1995
Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanomaW H Kruit, S H Goey, F Calabresi, et al.
Bone Marrow Transplantation|July 27, 2004
Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantationA Spyridonidis, A K Thomas, H Bertz, et al.
Human Gene Therapy|November 10, 1996
Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected fibroblastsF M Rosenthal, P Kulmburg, R Früh, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
FEBS Letters|September 17, 1990
Differential regulation of interleukin-6 expression in human fibroblasts by tumor necrosis factor-alpha and lymphotoxinL Mantovani, R Henschler, M A Brach, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 24, 2001
Trimethylsilyl- and trimethylstannyldimethylphosphane--convenient and versatile reagents for the synthesis of polyfluoroaryldimethylphosphanesL I Goryunov, J Grobe, V D Shteingarts, et al.
Blut|February 1, 1990
Erythropoietin prevents chemotherapy-induced anemia: case reportW Oster, F Herrmann, A Cicco, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1994
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2A Lindemann, P Brossart, K Höffken, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 1994
[Radiologic differential diagnosis of inflammatory round pulmonary infiltrates in immunocompromised patients. A prospective study using CT and MRT]U Blum, M Windfuhr, C Buitrago-Tellez, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB studyA Lindemann, P Brossart, K Höffken, et al.
Biotechnology Therapeutics|January 1, 1992
Combination of interleukin-2 and interferon-alpha in renal cell carcinoma and malignant melanoma: a phase II clinical trialH Veelken, F M Rosenthal, F Schneller, et al.
British Journal of Cancer|June 1, 1995
Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanomaW H Kruit, S H Goey, F Calabresi, et al.
Bone Marrow Transplantation|July 27, 2004
Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantationA Spyridonidis, A K Thomas, H Bertz, et al.
Human Gene Therapy|November 10, 1996
Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected fibroblastsF M Rosenthal, P Kulmburg, R Früh, et al.
Pageof 17